Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18,081 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Co-transducing B7H3 CAR-NK cells with the DNR preserves their cytolytic function against GBM in the presence of exogenous TGF-β.
Chaudhry K, Geiger A, Dowlati E, Lang H, Sohai DK, Hwang EI, Lazarski CA, Yvon E, Holdhoff M, Jones R, Savoldo B, Cruz CRY, Bollard CM. Chaudhry K, et al. Among authors: jones r. Mol Ther Methods Clin Dev. 2022 Oct 21;27:415-430. doi: 10.1016/j.omtm.2022.10.010. eCollection 2022 Dec 8. Mol Ther Methods Clin Dev. 2022. PMID: 36381305 Free PMC article.
Reduced-Intensity Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Solid Tumors in Pediatric and Young Adult Patients.
Llosa NJ, Cooke KR, Chen AR, Gamper CJ, Klein OR, Zambidis ET, Luber B, Rosner G, Siegel N, Holuba MJ, Robey N, Hayashi M, Jones RJ, Fuchs E, Holdhoff M, Loeb DM, Symons HJ. Llosa NJ, et al. Among authors: jones rj. Biol Blood Marrow Transplant. 2017 Dec;23(12):2127-2136. doi: 10.1016/j.bbmt.2017.08.012. Epub 2017 Aug 12. Biol Blood Marrow Transplant. 2017. PMID: 28807769 Free PMC article. Clinical Trial.
Allogeneic bone marrow transplantation with post-transplant cyclophosphamide for patients with HIV and haematological malignancies: a feasibility study.
Durand CM, Capoferri AA, Redd AD, Zahurak M, Rosenbloom DIS, Cash A, Avery RK, Bolaños-Meade J, Bollard CM, Bullen CK, Flexner C, Fuchs EJ, Gallant J, Gladstone DE, Gocke CD, Jones RJ, Kasamon YL, Lai J, Levis M, Luznik L, Marr KA, McHugh HL, Mehta Steinke S, Pham P, Pohlmeyer C, Pratz K, Shoham S, Wagner-Johnston N, Xu D, Siliciano JD, Quinn TC, Siliciano RF, Ambinder RF. Durand CM, et al. Lancet HIV. 2020 Sep;7(9):e602-e610. doi: 10.1016/S2352-3018(20)30073-4. Epub 2020 Jul 7. Lancet HIV. 2020. PMID: 32649866 Free PMC article. Clinical Trial.
Hematopoietic Cell Transplantation: Practice Predictions for the Year 2023.
Farhadfar N, Burns LJ, Mupfudze T, Shaw BE, Bollard CM, Devine SM, Horowitz MM, Jones RJ, Murthy HS, Wingard JR, Lee SJ. Farhadfar N, et al. Among authors: jones rj. Transplant Cell Ther. 2021 Feb;27(2):183.e1-183.e7. doi: 10.1016/j.bbmt.2020.10.006. Epub 2020 Oct 9. Transplant Cell Ther. 2021. PMID: 33045387 Free PMC article.
Allogeneic Blood or Marrow Transplantation with Nonmyeloablative Conditioning and High-Dose Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis for Secondary Central Nervous System Lymphoma.
Sterling CH, Tsai HL, Holdhoff M, Bolaños-Meade J, Luznik L, Fuchs EJ, Huff CA, Gocke CB, Ali SA, Borrello IM, Varadhan R, Jones RJ, Gladstone DE, Ambinder RF, Wagner-Johnston N, Swinnen LJ, Imus PH. Sterling CH, et al. Among authors: jones rj. Transplant Cell Ther. 2021 Oct;27(10):863.e1-863.e5. doi: 10.1016/j.jtct.2021.07.015. Epub 2021 Jul 20. Transplant Cell Ther. 2021. PMID: 34293518 Free article.
Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT.
Kinoshita H, Cooke KR, Grant M, Stanojevic M, Cruz CR, Keller M, Fortiz MF, Hoq F, Lang H, Barrett AJ, Liang H, Tanna J, Zhang N, Shibli A, Datar A, Fulton K, Kukadiya D, Zhang A, Williams KM, Dave H, Dome JS, Jacobsohn D, Hanley PJ, Jones RJ, Bollard CM. Kinoshita H, et al. Among authors: jones rj. Blood Adv. 2022 Apr 26;6(8):2520-2534. doi: 10.1182/bloodadvances.2021006831. Blood Adv. 2022. PMID: 35244681 Free PMC article. Clinical Trial.
Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide for Peripheral T Cell Lymphoma: The Importance of Graft Source.
Sterling CH, Hughes MS, Tsai HL, Yarkony K, Fuchs EJ, Swinnen LJ, Paul S, Bolaños-Meade J, Luznik L, Imus PH, Ali SA, Jain T, Ambinder A, DeZern A, Huff CA, Gocke CB, Varadhan R, Wagner-Johnston N, Jones RJ, Ambinder RF. Sterling CH, et al. Among authors: jones rj. Transplant Cell Ther. 2023 Apr;29(4):267.e1-267.e5. doi: 10.1016/j.jtct.2022.12.009. Epub 2022 Dec 19. Transplant Cell Ther. 2023. PMID: 36549386 Free PMC article. Review.
Profile of a Pioneer: George W. Santos.
Jones RJ. Jones RJ. Transplant Cell Ther. 2024 Sep;30(9):823-826. doi: 10.1016/j.jtct.2024.08.001. Transplant Cell Ther. 2024. PMID: 39179313 No abstract available.
18,081 results
You have reached the last available page of results. Please see the User Guide for more information.